TOX drives TH1 CD4+ T cell effector function, anti-tumor immunity, and pathogenicity in autoimmune diseases [RNA-Seq]
RNA-seq analysis of TOX WT and TOX KO transgenic (TCRSMARTA) CD4 T cells from tdLN of tumor-bearing mice day 11 post transfer Overall design: Naïve TOX WT and TOX KO TCRSMARTA CD4 T cells were transferred into B16-GP61 tumor-bearing hosts, and 11 days post transfer, sorted from tdLN and subjected to RNA-sequencing.